Anti-inflammatoryactivity of calciumchannel blocker lercanidipine hydrochloride.

Abstract

OBJECTIVE:

To evaluate the anti-inflammatory effect of the third-generation CCB, lercanidipine.

MATERIALS AND METHODS:

The ability of lercanidipine to reduce inflammation in carrageenan-induced paw edema in rats was evaluated, using different doses and its anti-inflammatory effect was compared with that of diclofenac sodium. Mast cell degranulation effect of lercanidipine was also carried out.

RESULTS:

Lercanidipine produced a significant reduction in the inflammatory paw edema at all doses and at all intervals (P < 0.001). The percentage of reduction in edema was found to be proportionate to the doses of lercanidipine. Lercanidipine also significantly reduced the percentage of propranolol-induced mast cell degranulation.

CONCLUSIONS:

It was found that lercanidipine exerts a positive anti-inflammatory effect in a dose-dependent manner and was superior to diclofenac sodium.

• Authors: Prathap Vasigar, Mounissamy Batmanabane
• Journal: Journal of pharmacology & pharmacotherapeutics (J Pharmacol Pharmacother) Vol. 4 Issue 4 Pg. 238-42 (Oct 2013) ISSN: 0976-500X [Print] India
• PMID: 24250199 (Publication Type: Journal Article)